The role of mergers and acquisitions in the pharmaceutical industry
At a glance
- The article titled "The role of mergers and acquisitions in the pharmaceutical industry" explores the significance of M&A in the pharmaceutical industry, its central role, and the driving force behind it.
- Corporate & Commercial Director Roxanna Valayathum and Candidate Attorney Carmin Jansen van Vuuren discuss the future prospects of the pharmaceutical industry and the broader life sciences sector, highlighting the potential impact of M&A.
- The article also provides a brief overview of M&A transactions in the pharmaceutical industry from a South African perspective.
They take a closer look at the role of M&A in the pharmaceutical industry, why M&A is central to such an industry, what the driving force is behind it, what the future potentially holds for the pharmaceutical industry and the broader life sciences industry. They also briefly consider M&A transactions from a South African perspective.
Click here to read the article.
The information and material published on this website is provided for general purposes only and does not constitute legal advice. We make every effort to ensure that the content is updated regularly and to offer the most current and accurate information. Please consult one of our lawyers on any specific legal problem or matter. We accept no responsibility for any loss or damage, whether direct or consequential, which may arise from reliance on the information contained in these pages. Please refer to our full terms and conditions. Copyright © 2024 Cliffe Dekker Hofmeyr. All rights reserved. For permission to reproduce an article or publication, please contact us cliffedekkerhofmeyr@cdhlegal.com.
Subscribe
We support our clients’ strategic and operational needs by offering innovative, integrated and high quality thought leadership. To stay up to date on the latest legal developments that may potentially impact your business, subscribe to our alerts, seminar and webinar invitations.
Subscribe
